All Journals > Clinical Infectious Diseases > 1 February 2007 > What is Antiretroviral Naive?

Article Tools

Search for Related Articles

  • By Author
  • Search In

Announcements

CID LISTED AMONG
“MOST INFLUENTIAL”

Clinical Infectious Diseases has been named as one of the "100 Most Influential Journals in Biology and Medicine" of the past 100 years by the Special Libraries Association. The list was compiled by the 680-plus members of SLA’s Biomedical and Life Sciences Division.

See the full list here.

Source: The DBIO 100, the 100 Most Influential Journals in Biology & Medicine over the last 100 Years

Press Release

Zambian Study Finds Longer Breastfeeding Best for HIV-Infected Mothers

Syphilis Survey Reveals Need for Accurate Testing for Early Infection

1 February 2007

Volume 44, Number 3
Clinical Infectious Diseases 2007;44:456–458
© 2006 by the Infectious Diseases Society of America. All rights reserved.
1058-4838/2007/4403-0026$15.00
DOI: 10.1086/510748
HIV/AIDS BRIEF REPORT

Clinical Utility of HIV Standard Genotyping among Antiretroviral‐Naive Individuals with Unknown Duration of Infection

Davey Smith,1,2

Niousha Moini,1

Rick Pesano, 3

Edward Cachay,1

Heidi Aiem,1

Yolanda Lie,3

Douglas Richman,1,2 and

Susan Little1

1University of California, San Diego, and 2Veterans Administration San Diego Healthcare System, San Diego, and 3Monogram Biosciences, South San Francisco, California

In clinical settings, we have found a high rate of human immunodeficiency virus (HIV) drug resistance among antiretroviral‐naive patients for whom the duration of infection was unknown. These high rates were most likely the result of both transmitted resistance and informal antiretroviral use, and they suggest that routine resistance testing among antiretroviral‐naive patients would be a cost‐effective clinical practice.

Received 23 August 2006; accepted 2 October 2006; electronically published 28 December 2006.

Reprints or correspondence: Dr. Davey Smith, Antiviral Research Center, University of California, San Diego, 150 W. Washington St., San Diego, CA 92103 ().

Cited by

Giovanina M Ellis, Libby C Page, Blaire E Burman, Susan Buskin, Lisa M Frenkel. (2009) Increased Detection of HIV-1 Drug Resistance at Time of Diagnosis by Testing Viral DNA With a Sensitive Assay. JAIDS Journal of Acquired Immune Deficiency Syndromes 51:3, 283-289
Online publication date: 1-Aug-2009.
CrossRef
Davey M Smith, Susanne J May, Samantha Tweeten, Lydia Drumright, Mary E Pacold, Sergei L Kosakovsky Pond, Rick L Pesano, Yolanda S Lie, Douglas D Richman, Simon DW Frost, Christopher H Woelk, Susan J Little. (2009) A public health model for the molecular surveillance of HIV transmission in San Diego, California. AIDS 23:2, 225-232
Online publication date: 1-Feb-2009.
CrossRef
Bluma G Brenner, Michel Roger, Daniela D Moisi, Maureen Oliveira, Isabelle Hardy, Reuven Turgel, Hugues Charest, Jean-Pierre Routy, Mark A Wainberg. (2008) Transmission networks of drug resistance acquired in primary/early stage HIV infection. AIDS 22:18, 2509-2515
Online publication date: 1-Dec-2008.
CrossRef
Vinod Trivedi, Jana Von Lindern, Miguel Montes-Walters, Daniel R. Rojo, Elisabeth J. Shell, Neil Parkin, William A. O'Brien, Monique R. Ferguson. (2008) Impact of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitor Drug Resistance Mutation Interactions on Phenotypic Susceptibility. AIDS Research and Human Retroviruses 24:10, 1291-1300
Online publication date: 1-Nov-2008.
CrossRef
Lin Liu, Susanne May, Douglas D Richman, Frederick M Hecht, Martin Markowitz, Eric S Daar, Jean-Pierre Routy, Joseph B Margolick, Ann C Collier, Christopher H Woelk, Susan J Little, Davey M Smith. (2008) Comparison of algorithms that interpret genotypic HIV-1 drug resistance to determine the prevalence of transmitted drug resistance. AIDS 22:7, 835-839
Online publication date: 1-May-2008.
CrossRef
Sandra de Meyer, Tony Vangeneugden, Ben van Baelen, Els de Paepe, Herwig van Marck, Gaston Picchio, Eric Lefebvre, Marie-Pierre de Béthune. (2008) Resistance Profile of Darunavir: Combined 24-Week Results from the POWER Trials. AIDS Research and Human Retroviruses 24:3, 379-388
Online publication date: 1-Apr-2008.
CrossRef
Shiro Ibe, Junko Hattori, Seiichiro Fujisaki, Urara Shigemi, Saeko Fujisaki, Kayoko Shimizu, Kazuyo Nakamura, Takejiro Kazumi, Yoshiyuki Yokomaku, Naoto Mamiya, Motohiro Hamaguchi, Tsuguhiro Kaneda. (2008) Trend of Drug-Resistant HIV Type 1 Emergence among Therapy-Naive Patients in Nagoya, Japan: An 8-Year Surveillance from 1999 to 2006. AIDS Research and Human Retroviruses 24:1, 7-14
Online publication date: 1-Feb-2008.
CrossRef
Back to Top
Close Popup